Bulevirtide

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Bulevirtide
Accession Number
DB15248
Description

Bulevirtide is under investigation in clinical trial NCT03852433 (Phase 2b Study of Bulevirtide (With Peginterferon Alfa-2a) in Patients With CHD).

Type
Biotech
Groups
Approved, Investigational
Biologic Classification
Protein Based Therapies
Peptides
Protein Chemical Formula
Not Available
Protein Average Weight
Not Available
Sequences
Not Available
Synonyms
Not Available

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Purchasing individual compounds or compound libraries for your research?
Learn More
Product Ingredients
IngredientUNIICASInChI Key
Bulevirtide acetateNot AvailableNot AvailableNot applicable
International/Other Brands
Hepcludex

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available

Chemical Identifiers

UNII
WKM56H3TLB
CAS number
2012558-47-1

References

General References
Not Available
Wikipedia
Bulevirtide

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3Active Not RecruitingTreatmentHepatitis D, Chronic1
2Active Not RecruitingTreatmentHepatitis D, Chronic1
2Unknown StatusTreatmentChronic Viral Hepatitis B With Delta-agent1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on May 20, 2019 09:04 / Updated on September 22, 2020 07:02

Logo pink
Are you using machine learning
in your drug discovery pipeline?
Learn more about integrating our machine-readable data into your algorithms, saving you time and money.